Last updated September 9, 2026
Key finding
Relative risk (95% CI) 1.20 (1.03–1.39) with a risk difference of 0.05 (0.01–0.10)
This study evaluated the effectiveness of electronic reminders for screening in women with gestational diabetes. Results indicated a modest increase in screening participation.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Long-Term (1–5 y)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
This study evaluated the effectiveness of electronic reminders for screening in women with gestational diabetes. Results indicated a modest increase in screening participation.
Improving screening rates for gestational diabetes is crucial for early detection and management of potential diabetes in women. Electronic reminders could serve as a low-cost intervention to enhance participation, ultimately leading to better health outcomes for mothers and their children.
Unclear effectiveness of the intervention on screening outcomes. Limited generalizability due to specific population characteristics. Potential unmeasured confounders affecting participation rates.
Published in
Publication details and source links for this paper.
Jane HN, Kirsten F, Jette KK, Charlotte O. Effectiveness of Electronic Reminders for Screening in Women with Gestational Diabetes: A Randomized Controlled Trial. BMC Public Health. 2023;23:153. doi:10.1186/s12889-023-15060-9
32.1% of women participated in screening, with 35.1% in the intervention group.
3.8% of those screened were diagnosed with type 2 diabetes.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Electronic reminder for screening and Diagnosis of type 2 diabetes, Participation rate in glycated hemoglobin screening.
This study contributes evidence to
Primary intervention
Electronic reminder for screening
Primary outcomes
Primary intervention
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
0
Related topics
2
Evidence pairs
0
Related studies
Core evidence
The primary outcomes reported in this study.
Electronic reminder for screening → Diagnosis of type 2 diabetes
Electronic reminder for screening → Diagnosis of type 2 diabetes
Electronic reminder for screening → Participation rate in glycated hemoglobin screening
Electronic reminder for screening → Participation rate in glycated hemoglobin screening
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Electronic reminder for screening and Diagnosis of type 2 diabetes, Electronic reminder for screening and Participation rate in glycated hemoglobin screening.
This study contributes to the evidence on the following intervention-outcome relationships.
Devices & Technology
Devices & Technology
Curated evidence collections and hubs this study is part of.
All studies measuring Diagnosis of type 2 diabetes
Measures Diagnosis of type 2 diabetes as a key outcome.
All studies on Electronic reminder for screening
Contributes to Electronic reminder for screening evidence base.
All studies measuring Participation rate in glycated hemoglobin screening
Measures Participation rate in glycated hemoglobin screening as a key outcome.
Jump to pre-filtered views in Evidence Explorer.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Electronic reminder for screening appears to lower participation rate in glycated hemoglobin screening.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Participation rate in glycated hemoglobin screening
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Electronic reminder for screening for diagnosis of type 2 diabetes.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Diagnosis of type 2 diabetes
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.
